CLAIM #43202 · Merck & Company Inc (MRK) · 2022Q3 earnings call · Oct 27, 2022 · due Dec 31, 2022
“We have increased and narrowed our expected EPS range to $7.32 to $7.37, an increase of $0.05 at the midpoint.”
Caroline Litchfield · CFO
PENDING
graded after results covering Dec 31, 2022 are reported
Verify independently
SEC filings for MRK ↗ · Claim quote is verbatim from the 2022Q3 earnings call.